Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metformin Effect on Nontargeted Metabolite Profiles in Patients With Type 2 Diabetes and in Multiple Murine Tissues.
Adam J, Brandmaier S, Leonhardt J, Scheerer MF, Mohney RP, Xu T, Bi J, Rotter M, Troll M, Chi S, Heier M, Herder C, Rathmann W, Giani G, Adamski J, Illig T, Strauch K, Li Y, Gieger C, Peters A, Suhre K, Ankerst D, Meitinger T, Hrabĕ de Angelis M, Roden M, Neschen S, Kastenmüller G, Wang-Sattler R. Adam J, et al. Among authors: ankerst d. Diabetes. 2016 Dec;65(12):3776-3785. doi: 10.2337/db16-0512. Epub 2016 Sep 12. Diabetes. 2016. PMID: 27621107
Response to Comment on Adam et al. Metformin Effect on Nontargeted Metabolite Profiles in Patients With Type 2 Diabetes and in Multiple Murine Tissues. Diabetes 2016;65:3776-3785.
Adam J, Brandmaier S, Troll M, Rotter M, Mohney RP, Heier M, Adamski J, Li Y, Neschen S, Kastenmüller G, Suhre K, Ankerst D, Meitinger T, Wang-Sattler R. Adam J, et al. Among authors: ankerst d. Diabetes. 2017 May;66(5):e3-e4. doi: 10.2337/dbi17-0010. Diabetes. 2017. PMID: 28507216 No abstract available.
Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in Germany.
Schmidt M, Ankerst DP, Chen Y, Wiethaler M, Slotta-Huspenina J, Becker KF, Horstmann J, Kohlmayer F, Lehmann A, Linkohr B, Strauch K, Schmid RM, Quante AS, Quante M. Schmidt M, et al. Cancer Prev Res (Phila). 2020 Apr;13(4):377-384. doi: 10.1158/1940-6207.CAPR-19-0474. Epub 2020 Feb 17. Cancer Prev Res (Phila). 2020. PMID: 32066580
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F; MMKD Study Group; Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P. Fliser D, et al. Among authors: ankerst dp. J Am Soc Nephrol. 2007 Sep;18(9):2600-8. doi: 10.1681/ASN.2006080936. Epub 2007 Jul 26. J Am Soc Nephrol. 2007. PMID: 17656479
150 results